Sukumar Nagendran, Director, President and Head of Research and Development, on July 10, 2026, sold 200,000 shares in Taysha Gene Therapies (TSHA) for $1,248,000. Following the Form 4 filing with the SEC, Nagendran has control over a total of 936,410 common shares of the company, with 936,410 shares held directly.
SEC Filing:
Tyler Page, Director, Chief Executive Officer, on July 08, 2026, sold 225,000 shares in Cipher Digital (CIFR) for $4,935,375. Following the Form 4 filing with the SEC, Page has control over a total of 9,371,725 common shares of the company, with 8,971,725 shares held directly and 400,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819989/000188762326000016/xslF345X05/wk-form4_1783720739.xml
Ajay Singh, Chief Product Officer, on July 08, 2026, sold 9,787 shares in Everpure (P) for $764,560. Following the Form 4 filing with the SEC, Singh has control over a total of 340,939 Class A common shares of the company, with 340,939 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1474432/000189794426000010/xslF345X05/wk-form4_1783719754.xml
Erez Shachar, Director, on July 08, 2026, sold 129,149 shares in Riskified (RSKD) for $671,463. Following the Form 4 filing with the SEC, Shachar has control over a total of 1,576,674 Class A ordinary shares of the company, with 80,053 shares held directly and 1,496,621 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1851112/000160109926000035/xslF345X05/wk-form4_1783718768.xml